News
Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
20h
News-Medical.Net on MSNTirzepatide reduces obesity-associated breast cancer growth in mouse modelThe anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results